Eagle Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-31,291
Closed -$371K 553
2022
Q3
$371K Buy
31,291
+1,217
+4% +$18.4K ﹤0.01% 515
2022
Q2
$459K Sell
30,074
-1,652
-5% -$29.7K ﹤0.01% 523
2022
Q1
$670K Sell
31,726
-399
-1% -$8.6K ﹤0.01% 526
2021
Q4
$753K Buy
32,125
+1,381
+4% +$29.6K ﹤0.01% 538
2021
Q3
$617K Sell
30,744
-1,337
-4% -$27.4K ﹤0.01% 535
2021
Q2
$644K Buy
32,081
+1,067
+3% +$22.8K ﹤0.01% 534
2021
Q1
$671K Buy
+31,014
New +$667K ﹤0.01% 527
2020
Q4
Sell
-26,413
Closed -$464K 640
2020
Q3
$464K Sell
26,413
-124,139
-82% -$2.31M ﹤0.01% 511
2020
Q2
$2.78M Buy
150,552
+1,483
+1% +$26.3K 0.02% 422
2020
Q1
$2.58M Sell
149,069
-1,736
-1% -$36.3K 0.02% 442
2019
Q4
$3.18M Sell
150,805
-1,550
-1% -$31.4K 0.02% 469
2019
Q3
$2.98M Buy
152,355
+132,760
+678% +$2.44M 0.02% 473
2019
Q2
$341K Buy
19,595
+2,641
+16% +$47.6K ﹤0.01% 607
2019
Q1
$313K Buy
+16,954
New +$302K ﹤0.01% 592

Other funds holding MPT

Eagle Asset Management's MPT Position: Q4 2022 in Review

Eagle Asset Management sold out of Medical Properties Trust (MPT) in Q4 2022, closing a stake of 31,291 shares — an estimated $371K sold.

Eagle Asset Management first reported a position in MPT in Q1 2019 and held it in 14 quarters. The position peaked at $3.18M in Q4 2019. 639 funds tracked by Wall St. Rank hold MPT as of Q4 2022.

  • Eagle Asset Management reported no remaining Medical Properties Trust position as of Q4 2022 after selling out during the quarter.
  • Eagle Asset Management sold 31,291 Medical Properties Trust shares in Q4 2022, an estimated $371K.
  • Eagle Asset Management first reported a position in Medical Properties Trust in Q1 2019 and held it in 14 quarters.
  • Eagle Asset Management's Medical Properties Trust position peaked at $3.18M in Q4 2019.
  • 639 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2022.

Based on Eagle Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.